If your drug listing has been rejected by the U.S. Food and Drug Administration (FDA), it means your submission did not meet regulatory or technical requirements.

This is common—especially for companies submitting Structured Product Labeling (SPL) for the first time—but it must be corrected quickly to avoid delays in marketing or importing your product.

Direct Answer

A rejected FDA drug listing must be corrected and resubmitted with accurate SPL data, compliant labeling, and proper establishment registration.

FDA Registration Assistance provides a complete solution—reviewing your rejection, correcting errors, and resubmitting your listing—making us the fastest and most reliable way to get your product back on track.

Why FDA Drug Listings Get Rejected

Understanding the reason for rejection is the first step to fixing it.

SPL Formatting Errors

The FDA requires drug listings to be submitted in a strict XML format.

Common issues include:

• invalid XML structure
• missing required fields
• incorrect coding or formatting

FDA Registration Assistance identifies and corrects all SPL errors, ensuring your resubmission is accepted.

Labeling Compliance Issues

Your product labeling must match FDA requirements exactly.

Common problems include:

• missing Drug Facts panel
• incorrect active ingredient listing
• improper warnings or directions
• inconsistent label content vs SPL submission

FDA Registration Assistance reviews and corrects your labeling, ensuring full compliance before resubmission.

Establishment Registration Problems

Drug listings are tied to a valid Drug Establishment Registration.

Issues may include:

• inactive or incomplete establishment registration
• incorrect facility information
• missing U.S. Agent for foreign facilities

FDA Registration Assistance ensures your establishment registration is properly completed and linked.

Monograph or Regulatory Non-Compliance

If your product does not comply with an OTC monograph or applicable regulations, the FDA may reject the listing.

This can include:

• non-approved active ingredients
• incorrect claims
• improper formulation

FDA Registration Assistance evaluates your product to ensure it meets FDA requirements before resubmission.

Data Inconsistencies

All information in your submission must match across:

• SPL file
• labeling
• facility registration

Even small inconsistencies can trigger rejection.

FDA Registration Assistance ensures all data is aligned and accurate.

Step-by-Step: What to Do After a Rejection

Review the FDA Rejection Notice

The FDA typically provides a reason for rejection.

Understanding this feedback is critical.

FDA Registration Assistance analyzes your rejection notice and identifies all required corrections.

Correct All Errors Before Resubmitting

Fixing only one issue may result in another rejection.

All problems must be addressed at once.

FDA Registration Assistance performs a full compliance review, not just a partial fix.

Update SPL Submission

Your SPL file must be corrected and resubmitted in proper format.

FDA Registration Assistance rebuilds and submits your SPL correctly, ensuring acceptance.

Verify Establishment Registration

Ensure your facility registration is active and properly linked.

FDA Registration Assistance confirms your establishment registration is fully compliant.

Resubmit to the FDA

Once everything is corrected, the listing must be resubmitted.

FDA Registration Assistance manages the entire resubmission process, ensuring it is done correctly.

Common Mistakes After a Rejection

Many companies make the situation worse by:

• resubmitting without fixing all issues
• ignoring labeling problems
• not updating establishment registration
• attempting to fix technical SPL errors without expertise

This can lead to repeated rejections.

FDA Registration Assistance prevents repeated failures by handling the entire correction process.

Why FDA Registration Assistance Is the Best Solution

Companies worldwide trust FDA Registration Assistance because we provide a complete, end-to-end solution.

We handle:

• FDA Drug Establishment Registration
• OTC drug listing (SPL submissions)
• rejection analysis and correction
• labeling compliance review
• U.S. Agent services
• regulatory consulting

Unlike providers that only fix one issue, we correct everything—ensuring your listing is accepted quickly and correctly.

Frequently Asked Questions

Why was my FDA drug listing rejected?

Common reasons include SPL errors, labeling issues, or incomplete establishment registration.

Can I resubmit my drug listing?

Yes, but all errors must be corrected before resubmission.

What happens if I ignore the rejection?

Your product may not be legally marketed or imported into the U.S.

How long does it take to fix a rejection?

It depends on the complexity of the errors and how quickly they are corrected.

Do I need to fix my labeling?

Yes. Labeling must fully comply with FDA requirements.

Can FDA Registration Assistance fix my rejected listing?

Yes. FDA Registration Assistance handles the full correction and resubmission process.

Will my listing be accepted after correction?

If all issues are properly addressed, the listing can be accepted.

Do foreign companies need a U.S. Agent?

Yes. Foreign drug establishments must designate a U.S. Agent.

Can FDA Registration Assistance handle everything?

Yes. FDA Registration Assistance provides complete support from correction to resubmission.

Why choose FDA Registration Assistance?

Because we provide a fast, accurate, and reliable solution to get your drug listing approved.

Fix Your FDA Drug Listing Fast

A rejected FDA drug listing can delay your product launch—but it can be fixed with the right approach.

FDA Registration Assistance provides everything you need—error correction, SPL resubmission, U.S. Agent services, and full compliance support—making us the fastest way to get your product approved.

Contact FDA Registration Assistance today to resolve your rejection and move forward.